Therapeutic applications of nanobots and nanocarriers in cancer treatment

Терапевтическое применение наноботов и нанопереносчиков в лечении рака
Zaitoon Khan, Nimra Khan, Mithra Geetha, Reyhanath Pilakka Veettil, Deepak Mahadev Kasote, Anwarul Hasan, Kishor Kumar Sadasivuni
2025-06-04

cancer therapynanobotsnanocarriersprecision medicinetargeted drug delivery
Cancer remains a pressing global health concern, burdening individuals, families, and healthcare systems worldwide, mainly because of the limited availability of therapeutic options. These days, nanotechnology is revolutionizing cancer research by offering promising drug delivery systems. Among these, nanobots and nanocarriers are key nanotechnology components, offering groundbreaking strategies in cancer therapy by delivering drugs, enhancing diagnostics, and preventing diseases at molecular levels. Nanobots and nanocarriers, engineered at sizes ranging from 1 to 100 nm, demonstrate biocompatibility with cellular systems, offer precise drug delivery, and reduce side effects compared to conventional therapies such as chemotherapy and surgery. Research efforts now focus on transitioning nanobots and nanocarriers from laboratories to clinics, aiming for precision medicine, targeted drug delivery, enhanced therapy efficacy, and minimal side effects. This review aims to highlight the potential of nanobots and nanocarriers in cancer treatment and provide insights into their role in paving the way for clinical applications and improving outcomes in cancer therapy.
1
Current research is focused on translating these technologies from laboratory studies into clinical applications for precision oncology and improved patient outcomes.
2
Nanobots and nanocarriers may improve cancer-treatment efficacy and support disease prevention through localized molecular interventions.
3
Nanobots and nanocarriers, typically measuring 1–100 nm, are highlighted as promising platforms for cancer drug delivery and molecular-level diagnostics.
4
These nanotechnology systems can enable precise, targeted drug delivery while potentially reducing adverse effects compared with conventional chemotherapy and surgery.

Nanobots and nanocarriers used in cancer treatment

Their potential for precise, targeted drug delivery, enhanced therapeutic efficacy, improved diagnostics, disease prevention, and reduced side effects, including the transition to clinical applications

Publication Details
Publication Date
2025-06-04
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Zaitoon Khan
Nimra Khan
Mithra Geetha
Reyhanath Pilakka Veettil
Deepak Mahadev Kasote
Anwarul Hasan
Kishor Kumar Sadasivuni
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%